Macrogenics (MGNX) Shares Outstanding (2012 - 2026)

Macrogenics (MGNX) has reported Shares Outstanding (Entity) for 15 consecutive years, with $63.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 0.74% year-over-year to $63.6 million; the TTM figure through Mar 2026 stood at $63.6 million (up 0.74% YoY), while the FY2025 annual figure was $63.3 million, up 0.79% from the prior year.
• Shares Outstanding (Entity) was little changed at $63.6 million in Q1 2026 per MGNX's latest filing, from $63.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $63.6 million in Q1 2026 and bottomed at $61.3 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $62.4 million across 5 years, with a median of $62.6 million in 2024.
• On a YoY basis, Shares Outstanding (Entity) climbed as much as 2.2% in 2022 and fell as far as 0.34% in 2022.
• Macrogenics' Shares Outstanding (Entity) stood at $61.7 million in 2022, then advanced by 0.6% to $62.1 million in 2023, then grew by 1.21% to $62.8 million in 2024, then grew by 0.79% to $63.3 million in 2025, then grew by 0.38% to $63.6 million in 2026.
• Business Quant data shows MGNX's Shares Outstanding (Entity) at $63.6 million in Q1 2026, $63.3 million in Q4 2025, and $63.3 million in Q3 2025.